Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
02/2001
02/07/2001EP1073626A1 Azine used as fungicides
02/07/2001CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas
02/06/2001US6184386 Compound for photography
02/06/2001US6184385 Novel method for recovering the product, addition of water to the solvent slurry and the isolating of the product by a single filtration step, santocure?
02/06/2001US6184210 Dipeptide-based caspase (proteolytic family of cysteine proteases whose active site cysteine residue is essential for ice-mediated apoptosis) inhibitors of given formula are potent inhibitors of apoptosis
02/01/2001WO2001007426A1 Method for producing 4-cyano-2-aminomethylthiazol
02/01/2001WO2001007425A1 Method for producing 2-aminomethyl-4-cyano-thiazol
02/01/2001WO2001007424A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
02/01/2001WO2001007423A1 Drug compositions exhibiting thrombopoietin agonism
02/01/2001WO2001007411A1 Biarylurea derivatives
02/01/2001WO2001007405A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
02/01/2001WO2001007029A2 Substituted guanidines and the use thereof
02/01/2001WO2000058405A3 Squaraine dyes
02/01/2001DE19935771A1 Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with cyclic substructures in the side chains, to processes and intermediates for their preparation and to the use for the preparation of medicaments
02/01/2001CA2380389A1 Biarylurea derivatives
02/01/2001CA2380206A1 Pharmaceutical compositions exhibiting thrombopoietin receptor agonism
02/01/2001CA2376465A1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
01/2001
01/31/2001EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
01/31/2001EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide
01/31/2001EP1071648A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
01/31/2001CN1282326A Anilide derivative, production and use thereof
01/31/2001CN1282325A Arylthiazolidinedione derivatives
01/31/2001CN1282324A Thiazole-, isothiazole-and thiadiazole-derivatives having microbicidal and plant immunizing activities
01/31/2001CN1282319A Aminobutanoic acid derivatives
01/31/2001CN1061339C Novel sulfonamide inhibitors of aspartyl protease
01/30/2001US6180796 Sulfonamide derivatives
01/30/2001US6180795 Process for making N-alkyl bis(thiazolyl)sulfenimides
01/30/2001US6180675 IL-8 receptor antagonists
01/30/2001US6180654 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
01/25/2001WO2001005777A1 Substituted heteroaryloxyacetanilides and their use as herbicides
01/25/2001WO2001005776A1 Aminothiazole derivatives and their use as crf receptor ligands
01/25/2001WO2001005769A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/25/2001WO2001005767A1 Organic compounds
01/25/2001WO2001005756A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
01/25/2001WO2001005742A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
01/25/2001WO2001005402A1 Preventive and therapeutic agents for cancer
01/25/2001WO2001005390A2 Method for treating chronic pain using mek inhibitors
01/25/2001WO2001005230A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof
01/25/2001WO2000058293A3 Glucokinase activators
01/25/2001WO2000054756A3 Nitrate esters and their use for introducing neuroprotection and cognition enhancement
01/25/2001DE19934066A1 New 2-aminomethyl-4-cyanothiazole, prepared from N-(tert. butoxycarbonyl)-aminoacetonitrile and cysteine ester, used as intermediate for serine protease inhibitors, e.g. thrombin inhibitors
01/25/2001DE19933936A1 Substituierte Heteroaryloxyacetanilide Substituted heteroaryloxyacetanilides
01/25/2001DE19933861A1 New 2-aminomethyl-4-cyanothiazole, prepared from thioamide and bromopyruvate ester, used as intermediate for serine protease inhibitors, e.g. thrombin inhibitors
01/25/2001CA2379891A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
01/25/2001CA2379662A1 Preventive and therapeutic agents for cancer
01/25/2001CA2379562A1 Substituted heteroaryloxyacetanilides and their use as herbicides
01/25/2001CA2377092A1 Method for treating chronic pain using mek inhibitors
01/25/2001CA2375954A1 Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof
01/24/2001EP1070052A1 Fungicide compositions comprising a hydroximic or hydrazonic group
01/24/2001EP1070046A1 Propanolamine derivatives
01/24/2001CN1281451A Benzamine derivatives
01/24/2001CN1281442A Novel compounds useful as neuro-protective agents
01/24/2001CN1281438A Piperazine compounds and medical use thereof
01/24/2001CN1281437A Method for producing isoureas
01/24/2001CN1281436A N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
01/24/2001CN1281430A N-alkanoylphenylalanine derivatives
01/24/2001CN1281359A Use of thiazolidinediones for treatment of hyperglycaemia
01/24/2001CN1281358A Use of thiazolidinediones for treatment of hyperglycaemia
01/24/2001CN1280818A Application of ring enamine as light stability agent
01/24/2001CN1061045C Process for preparation of new cephalosporins containing in position 7 substituted benzyloxyimino radical
01/24/2001CN1061042C Adhesion receptor antagonists
01/23/2001USRE37029 Antipsychotic and analgesic agents
01/23/2001US6177573 Process to prepare taxol
01/23/2001US6177572 Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use
01/23/2001US6177459 Substituted heterocyclic compounds and their use as fungicides
01/23/2001US6177454 Antidiabetic agents
01/23/2001US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis
01/18/2001WO2001004116A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them
01/18/2001WO2001004115A2 Novel process for synthesis of heteroaryl-substituted urea compounds
01/18/2001WO2001004097A2 Cyclic delocalized cations connected by spacer groups
01/18/2001WO2000060027A3 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring
01/18/2001DE19932495A1 N-(2-Mercaptoethyl)-1,3-thiazolidine und deren Verwendung als Riech- und Aromastoffe N- (2-mercaptoethyl) -1,3-thiazolidine and their use as perfume and aromatic substances
01/18/2001DE19932494A1 4-Alkanoyl-3-thazoline und deren Verwendung als Riech- und Aromastoffe 4-alkanoyl-3-thazoline and their use as perfume and aromatic substances
01/18/2001CA2379149A1 Neurotrophic pyrrolidines and piperidines, and related compositions and methods
01/17/2001EP1069118A1 Process for producing 4-thiazolylmethyl derivative
01/17/2001EP1069117A1 4-Alkanoyl-3-thiazolines and their use as fragrances and flavourings
01/17/2001EP1069116A1 N-(2-Mercaptoethyl)-1,3-thiazolidines and their use as fragrances and flavourings
01/17/2001EP1069111A1 Indole derivatives with antiviral activity
01/17/2001EP1069110A1 Sulfonamide derivatives
01/17/2001EP1068211A2 Process for purification of a cephalosporin derivative
01/17/2001EP1068203A1 Process for the preparation of nitroguanidine derivatives
01/17/2001EP1068196A1 Nitrate salt of anti-ulcer medicine
01/17/2001EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds
01/17/2001CN1280561A Amidocarboxylic acid derivatives
01/17/2001CN1280560A Adamantane derivatives
01/17/2001CN1060615C Guanidine derivatives insecticides composition
01/16/2001US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound
01/16/2001US6174922 Sulphonamide derivatives
01/16/2001US6174908 Treating disease, condition, or disorder which responds to inhibition of potassium channel function by administering thiazolidone or metathiazonone compound, its salt, amide, ester, complex, chelate, hydrate, stereoisomer, metabolite
01/16/2001US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma
01/16/2001US6174904 Treating glycometabolism disorders in mammals by administering therapeutically effective amount of an insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor
01/16/2001US6174839 As herbicide
01/16/2001CA2010800C Protein labelling
01/11/2001WO2001002394A1 Substituted indole compounds and their use for the treatment of cancer
01/11/2001WO2001002379A1 Selective npy (y5) antagonists
01/11/2001WO2001002378A1 Nematicidal trifluorobutenes
01/11/2001WO2001002377A1 Telomerase inhibitors and methods of their use
01/11/2001WO2001002376A1 Amino-alkyl derivatives
01/11/2001WO2001002362A1 Azo amino acid derivatives for the treatment of neurological diseases
01/11/2001WO2001002359A1 Heterocyclic compounds and medicinal use thereof